DBV Technologies (DBVT) EBT Margin (2020 - 2026)
DBV Technologies (DBVT) reported EBT Margin of 5266.67% for Q1 2026, down 187917.0% year-over-year from N/an in Q1 2025, and up 23.59% quarter-over-quarter from 6892.25% in Q4 2025.
DBV Technologies (DBVT) EBT Margin (2020 - 2026) Analysis & Trends
DBV Technologies (DBVT) has 7 years of EBT Margin data on file, last reported at 5266.67% in Q1 2026.
- EBT Margin for Q1 2026 came in at 5266.67%, down 187917.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 2883.42% (up 32386.0% YoY), and the FY2025 annual result was 2598.58%, up 14445.0% from the prior year.
- EBT Margin improved to 5266.67% in Q1 2026 per DBVT's latest filing, from 6892.25% in the prior quarter.
- Over five years, EBT Margin peaked at 3010.58% in Q4 2022 and troughed at 6892.25% in Q4 2025.
- A 5-year average of 2031.61% and a median of 1506.8% in 2022 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2022 and 2024: EBT Margin surged 347610 bps in 2022, then slumped 437644 bps in 2024.
- A 5-year view of EBT Margin shows it stood at 3010.58% in 2022, then sank by 104 bps to 126.11% in 2023, then sank by 3470 bps to 4502.54% in 2024, then sank by 53 bps to 6892.25% in 2025, then climbed by 24 bps to 5266.67% in 2026.
- Business Quant data shows DBVT's EBT Margin at 5266.67% in Q1 2026, 6892.25% in Q4 2025, and 1195.53% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | DBV Technologies | 6.63 Bn | 6.41 Bn | -3.90 Mn | -5,266.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,266.67% |
| Dec 31, 2025 | -6,892.25% |
| Sep 30, 2025 | -1,195.53% |
| Jun 30, 2025 | -2,850.38% |
| Mar 31, 2025 | -3,387.50% |
| Dec 31, 2024 | -4,502.54% |
| Sep 30, 2024 | -2,839.74% |
| Jun 30, 2024 | -2,852.37% |
| Mar 31, 2024 | -1,940.09% |
| Dec 31, 2023 | -126.11% |
| Sep 30, 2023 | -705.56% |
| Jun 30, 2023 | -1,059.00% |
| Mar 31, 2023 | -937.15% |
| Dec 31, 2022 | 3,010.58% |
| Sep 30, 2022 | -833.51% |
| Jun 30, 2022 | -1,506.80% |
| Mar 31, 2022 | -652.75% |
| Dec 31, 2021 | -465.52% |
| Sep 30, 2021 | -1,816.55% |
| Jun 30, 2021 | -2,089.25% |